abstract |
The invention relates to the use of at least one fumaric acid derivative as an NF-kappaB inhibitor. The invention also relates to the use of fumaric acid derivatives for producing a pharmaceutical preparation for the treatment of disorders which can be influenced by NF-kappaB. |